A detailed history of Creative Planning transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Creative Planning holds 177,055 shares of KURA stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
177,055
Previous 136,259 29.94%
Holding current value
$1.98 Million
Previous $786,000 99.24%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$5.54 - $9.05 $226,009 - $369,203
40,796 Added 29.94%
177,055 $1.57 Million
Q2 2025

Aug 08, 2025

BUY
$5.55 - $6.92 $382,722 - $477,196
68,959 Added 102.47%
136,259 $786,000
Q1 2025

May 15, 2025

BUY
$6.6 - $9.05 $218,684 - $299,862
33,134 Added 96.98%
67,300 $444,000
Q4 2024

Feb 14, 2025

BUY
$8.51 - $19.21 $290,752 - $656,328
34,166 New
34,166 $297,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $749M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.